S. Talegaonkar

发表

Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery

R. Wimmer, P. Mishra, J. Bhandari, 2017, International journal of nanomedicine.

Development and Validation of Reversed Phase HPLC Method for the Simultaneous Detection of Lactone and Carboxylate Forms of Topotecan Along with Thymoquinone: Application to Nanoparticulate Anticancer Formulation System

S. Talegaonkar, Devina Verma, M. A. Mirza, 2020, Journal of Analytical Chemistry.

Design and in vitro/in vivo evaluations of a multiple-drug-containing gingiva disc for periodontotherapy

S. Talegaonkar, M. Anwer, S. Alshahrani, 2020, RSC advances.

Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications.

P. Mishra, Harshita Mishra, S. Talegaonkar, 2017, Drug discovery today.

Functionalized nanoliposomes loaded with anti survivin and anti angiogenic agents to enhance the activity of chemotherapy against melanoma by 4-pronged action.

P. Mishra, Harshita Mishra, S. Talegaonkar, 2018, Medical hypotheses.

Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

Sushama Talegaonkar, S. Talegaonkar, R. Khar, 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Engineered Site Specific Vesicular Systems for Colonic Delivery: Trends and Implications.

S. Talegaonkar, A. Tiwary, V. Sinha, 2020, Current pharmaceutical design.

Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.

S. Talegaonkar, A. Verma, Z. Iqbal, 2016, Colloids and surfaces. B, Biointerfaces.

Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability

S. Talegaonkar, A. Bhattacharyya, 2019, AAPS PharmSciTech.

Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies.

F. Ahmad, S. Talegaonkar, S. Akhter, 2013, Colloids and surfaces. B, Biointerfaces.

The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review

F. Ahmad, S. Talegaonkar, N. Akhtar, 2011, Expert opinion on therapeutic patents.

Revisiting the nanoformulation design approach for effective delivery of topotecan in its stable form: an appraisal of its in vitro Behavior and tumor amelioration potential

S. Talegaonkar, Devina Verma, M. A. Mirza, 2016, Drug delivery.

Development of Celecoxib Complexes: Characterization and Cytotoxicity Studies in MCF-7

A. Alam, S. Talegaonkar, M. A. Mirza, 2013 .

Niosomes in sustained and targeted drug delivery: some recent advances

S. Talegaonkar, M. Anwer, A. Azeem, 2009, Journal of drug targeting.

Quality by design driven development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: An in vitro and in vivo assessments

S. Talegaonkar, A. Verma, M. Aqil, 2019, Journal of Drug Delivery Science and Technology.

Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.

Gautam Mishra, S. Talegaonkar, R. Khar, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.

S. Talegaonkar, R. Khar, M. Jaggi, 2008, Life sciences.

Chemical penetration enhancers: a patent review

S. Talegaonkar, A. Ahad, K. Kohli, 2009, Expert opinion on therapeutic patents.

A vaginal drug delivery model

S. Talegaonkar, Devina Verma, M. A. Mirza, 2016, Drug delivery.

Formulation development and in vitro-in vivo assessment of protransfersomal gel of anti-resorptive drug in osteoporosis treatment.

R. Trivedi, F. Ahmad, S. Talegaonkar, 2021, International journal of pharmaceutics.

Exploring nanoencapsulation of aroma and flavors as new frontier in food technology

S. Talegaonkar, N. Kumari, Purnima Rawat, 2016 .

Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part II. In vivo biodistribution, pharmacodynamic and hematological toxicity studies.

S. Talegaonkar, A. Verma, Ritu Verma, 2014, Colloids and surfaces. B, Biointerfaces.

Role of CD44 in tumour progression and strategies for targeting

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2012, Journal of drug targeting.

Smart Polymers in Targeted Drug Delivery

S. Talegaonkar, Sobiya Zafar, Harshita Sharma, 2016 .

Nanoformulations: Opportunities and Challenges

M. Rai, Harshita Mishra, S. Talegaonkar, 2020 .

Formulations of Nanoparticles in Drug Delivery

S. Talegaonkar, Z. Iqbal, M. Tariq, 2013 .

Surface engineered nanostructured lipid carriers for targeting MDR tumor: Part I. Synthesis, characterization and in vitro investigation.

S. Talegaonkar, A. Verma, Ritu Verma, 2014, Colloids and surfaces. B, Biointerfaces.

Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessment.

Sarika Gupta, D. Vohora, F. Ahmad, 2016, International journal of pharmaceutics.

Nanocrystalization: An Emerging Technology to Enhance the  Bioavailability of Poorly Soluble Drugs

S. Talegaonkar, K. Jain, A. Chandra, 2019, Pharmaceutical nanotechnology.

Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: Optimization, in vitro characterization and stability assessment

S. Talegaonkar, Devina Verma, Tahir Khuroo, 2017 .

Preparation, evaluation and pharmacokinetic studies of spray dried PLGA polymeric submicron particles of simvastatin for the effective treatment of breast cancer

S. Talegaonkar, S. Alshahrani, A. Alshetaili, 2018 .

Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.

F. Ahmad, S. Talegaonkar, G. Jain, 2014, Colloids and surfaces. B, Biointerfaces.

Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticle.

P. Mishra, Harshita Mishra, S. Talegaonkar, 2018, Medical hypotheses.

Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation

S. Talegaonkar, A. Verma, M. Jaggi, 2018, Journal of drug targeting.

Combined Raloxifene and Letrozole for Breast Cancer Patients.

D. Vohora, S. Talegaonkar, A. Verma, 2017, Archives of medical research.

Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2016, Journal of Cancer Research and Clinical Oncology.

Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female mice

D. Vohora, S. Talegaonkar, A. Kalam, 2016, Fundamental & clinical pharmacology.

Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation.

S. Talegaonkar, M. Tariq, L. Negi, 2013, Colloids and surfaces. B, Biointerfaces.

Microbial Iron Chelators: A Sustainable Tool for the Biocontrol of Plant Diseases

S. Talegaonkar, S. Chincholkar, B. Chaudhari, 2000 .

Microemulsions: a novel approach to enhanced drug delivery.

F. Ahmad, S. Talegaonkar, R. Khar, 2008, Recent patents on drug delivery & formulation.

Hyaluronic acid decorated lipid nanocarrier for MDR modulation and CD-44 targeting in colon adenocarcinoma.

S. Talegaonkar, M. Jaggi, L. Negi, 2015, International journal of biological macromolecules.

Recent approaches for the treatment of periodontitis.

F. Ahmad, S. Talegaonkar, G. Jain, 2008, Drug discovery today.

Facile functionalization of Teriflunomide-loaded nanoliposomes with Chondroitin sulphate for the treatment of Rheumatoid arthritis.

S. Talegaonkar, M. Aqil, Y. Neupane, 2020, Carbohydrate polymers.

Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations

S. Talegaonkar, Z. Iqbal, A. Panda, 2016, Drug delivery.

Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation.

S. Talegaonkar, N. Akhtar, R. Khar, 2013, Journal of biomedical nanotechnology.

Concurrent determination of topotecan and model permeability markers (atenolol, antipyrine, propranolol and furosemide) by reversed phase liquid chromatography: utility in Caco-2 intestinal absorption studies.

Gautam Mishra, S. Talegaonkar, R. Mukherjee, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations

F. Ahmad, S. Talegaonkar, A. Verma, 2018, Pharmaceutical Research.

Nanofacilitated synergistic treatment for rheumatoid arthritis: A 'three-pronged' approach.

F. Ahmad, S. Talegaonkar, Purnima Rawat, 2016, Medical hypotheses.

EMERGING TRENDS IN ORAL BIOAVAILABILITY ENHANCEMENT

S. Talegaonkar, A. M. Khan, M. Tariq, 2018 .

Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice

D. Vohora, S. Talegaonkar, A. Kalam, 2017, Molecular and Cellular Endocrinology.

Design and development of bioinspired calcium phosphate nanoparticles of MTX: pharmacodynamic and pharmacokinetic evaluation

S. Talegaonkar, Farhan Jalees Ahmad, Asiya Mahtab, 2019, Drug development and industrial pharmacy.

Vesicular systems: An overview

S. Talegaonkar, P. Mishra, R. Khar, 2006 .

V Vesicular Systems: An Overview esicular Systems: An Overview esicular Systems: An Overview esicular Systems: An Overview esicular Systems: An Overview

P. Mishra, S. Talegaonkar, R. Khar, 2006 .

Enhanced transdermal drug delivery techniques: an extensive review of patents.

M. Rizwan, S. Talegaonkar, Asgar Ali, 2009, Recent patents on drug delivery & formulation.

Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations

S. Talegaonkar, Md. Aftab Alam, A. Panda, 2016, Drug delivery.

Bionanocomposites: smart biodegradable packaging material for food preservation

R. Wimmer, P. Mishra, S. Talegaonkar, 2017 .

The Ameliorated Pharmacokinetics of VP-16 in Wistar Rats: A Possible Role of P-Glycoprotein Inhibition by Pharmaceutical Excipients

S. Talegaonkar, N. Akhtar, A. Ahad, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

DESIGN AND DEVELOPMENT OF O/W NANOEMULSION FOR THE TRANSDERMAL DELIVERY OF ONDANSETRON

S. Talegaonkar, Raid M. Alabood, 2011 .

Inverse targeting of diclofenac sodium to reticuloendothelial system-rich organs by sphere-in-oil-in-water (s/o/w) multiple emulsion containing poloxamer 403

S. Talegaonkar, S. P. Vyas, 2005, Journal of drug targeting.

Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.

S. Talegaonkar, M. Jaggi, L. Negi, 2015, International journal of biological macromolecules.

Hyaluronate-functionalized hydroxyapatite nanoparticles laden with methotrexate and teriflunomide for the treatment of rheumatoid arthritis.

F. Ahmad, S. Talegaonkar, A. Verma, 2021, International journal of biological macromolecules.

Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.

S. Talegaonkar, Devina Verma, Tahir Khuroo, 2014, International journal of pharmaceutics.

Simultaneous Determination of Hydrophilic and Lipophilic Drugs in Anti-Cancer Liposomes: Absorptivity Method

P. Mishra, Harshita Mishra, S. Talegaonkar, 2019, Indian Journal of Pharmaceutical Education and Research.

NANOEMULSIONS:FORMULATION METHODS AND STABILITY ASPECTS

S. Talegaonkar, S. Setya, 2014 .

Multiple emulsions: an overview.

S. Talegaonkar, Z. Iqbal, F. Ahmed, 2006, Current drug delivery.

Nanoemulsion Components Screening and Selection: a Technical Note

M. Rizwan, F. Ahmad, S. Talegaonkar, 2009, AAPS PharmSciTech.

Three Ply-Walled Microcapsules for Enhanced Pharmacokinetics of Poorly Absorbed Risedronate Sodium: Novel Stratagem Toward Osteoporosis

D. Vohora, F. Ahmad, S. Talegaonkar, 2015, Journal of Pharmaceutical Innovation.

Treatment modalities and evaluation models for periodontitis

S. Baboota, J. Ali, S. Talegaonkar, 2012, International journal of pharmaceutical investigation.

Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma

P. Mishra, Harshita Mishra, S. Talegaonkar, 2019, Pharmaceutics.

Formulation development and optimization of alpha ketoglutarate nanoparticles for cyanide poisoning

F. Ahmad, S. Talegaonkar, G. Mittal, 2011 .

Nonionic Surfactant Vesicles as a Carrier for Transdermal Delivery of Frusemide

F. Ahmad, S. Talegaonkar, A. Azeem, 2008 .

Feasibility of Proniosomes-Based Transdermal Delivery of Frusemide: Formulation Optimization and Pharmacotechnical Evaluation

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2008 .

Potential of a novel self nanoemulsifying carrier system to overcome P-glycoprotein mediated efflux of etoposide: In vitro and ex vivo investigations

S. Talegaonkar, N. Akhtar, A. Ahad, 2015 .

A novel and multifaceted excipient for vaginal drug delivery

S. Talegaonkar, M. A. Mirza, Z. Iqbal, 2011 .

A novel and multifunctional excipient for vaginal drug delivery

F. Ahmad, S. Talegaonkar, M. A. Mirza, 2011 .

Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability

S. Talegaonkar, A. Bhattacharyya, 2019, AAPS PharmSciTech.

EXTRACTION OF A WATER SOLUBLE BIOACTIVE HYPOXOSIDE AND ITS DEVELOPMENT INTO AN ETHOSOMAL SYSTEM FOR DEEP DERMAL DELIVERY

S. Talegaonkar, Devina Verma, Tahir Khuroo, 2015 .

Enhanced transdermal delivery of carvedilol using nanoemulsion as a vehicle

M. Rizwan, S. Talegaonkar, Asgar Ali, 2010 .

Nanoemulgel: a promising novel formulation for treatment of skin ailments

S. Talegaonkar, K. Jain, Surabhi Gupta, 2021, Polymer Bulletin.

Design and Development of Ciclopirox Topical Nanoemulsion Gel for the Treatment of Subungual Onychomycosis

S. Talegaonkar, L. Negi, Sushil Kumar, 2012 .

QUANTITATIVE ANALYSIS OF ITRACONAZOLE IN BULK, MARKETED, AND NANO FORMULATION BY VALIDATED, STABILITY INDICATING HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY

S. Talegaonkar, M. A. Mirza, Z. Iqbal, 2012 .

Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations

S. Talegaonkar, Z. Iqbal, L. Negi, 2015 .

Nanocarrier for the Transdermal Delivery of an Antiparkinsonian Drug

F. Ahmad, S. Talegaonkar, R. Khar, 2009, AAPS PharmSciTech.

Microemulsions as a Surrogate Carrier for Dermal Drug Delivery

F. Ahmad, S. Talegaonkar, M. Aqil, 2009, Drug development and industrial pharmacy.

Development of Ethanolic Nano Vesicles of Tenoxicam, Investigation of Transdermal Penetration Efficiency and Histological Safety Comparison with Common Penetration Enhancers

S. Talegaonkar, M. Chauhan, L. Negi, 2013 .

Exploration of skin permeation mechanism of frusemide with proniosomes.

F. Ahmad, S. Talegaonkar, A. Azeem, 2009, Die Pharmazie.

Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation.

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2008, Pharmaceutical development and technology.

Development and optimization of ketoconazole loaded nano-transfersomal gel for vaginal delivery using Box-Behnken design: In vitro, ex vivo characterization and antimicrobial evaluation

S. Talegaonkar, M. Anwer, Devina Verma, 2017 .

Fabrication design, process technologies, and convolutions in the scale-up of nanotherapeutic delivery systems

S. Talegaonkar, L. Siddiqui, H. Goel, 2022, Nanoparticle Therapeutics.

Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.

Sushama Talegaonkar, S. Talegaonkar, N. Akhtar, 2009, Drug discovery today.

Encapsulation via Microemulsion

S. Talegaonkar, Harshita Sharma, L. Negi, 2015 .

Investigation of Nanoemulsion System for Transdermal Delivery of Domperidone: Ex-vivo and in vivo Studies

F. Ahmad, S. Talegaonkar, S. Akhter, 2008 .

Biocompatible nanovesicular drug delivery systems with targeting potential for autoimmune diseases.

S. Talegaonkar, L. Siddiqui, Y. Neupane, 2020, Current pharmaceutical design.

Development of a novel synergistic thermosensitive gel for vaginal candidiasis: an in vitro, in vivo evaluation.

S. Talegaonkar, M. A. Mirza, Z. Iqbal, 2013, Colloids and surfaces. B, Biointerfaces.

Design, development and evaluation of self-microemulsifying drug delivery system of pazopanib for enhanced dissolution rate and cytotoxic potential

S. Talegaonkar, K. Dubey, Devender Kumar, 2023, Journal of Drug Delivery Science and Technology.

Nanopotentiated combination cancer therapy: Chemotherapeutic and chemosensitizer (2C approach).

S. Talegaonkar, Devina Verma, Tahir Khuroo, 2015, Medical hypotheses.

Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting.

Sushama Talegaonkar, F. Ahmad, S. Talegaonkar, 2013, Colloids and surfaces. B, Biointerfaces.

Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation.

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2012, International journal of pharmaceutics.

Enhanced transdermal delivery of lutein via nanoethosomal gel: Formulation optimization, in-vitro evaluation, and in-vivo assessment

S. Talegaonkar, P. Kesharwani, Z. Iqbal, 2022, Journal of Drug Delivery Science and Technology.

In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis

S. Talegaonkar, Z. Iqbal, M. Mirza, 2012 .

Lutein, a versatile phyto-nutraceutical: An insight on pharmacology, therapeutic indications, challenges and recent advances in drug delivery

D. Vohora, Harshita Mishra, S. Talegaonkar, 2017 .

Quantification of Tamoxifen Polymeric Nanoparticles in female rodent breast tissue by UPLC/ESI-Q-TOF MS/MS

A. Alam, F. Ahmad, S. Talegaonkar, 2016 .

DESIGN, DEVELOPMENT AND IN VITRO INVESTIGATION OF WATER IN OIL NANOEMULSION FOR TRANSDERMAL DELIVERY

S. Talegaonkar, S. Setya, P. Negi, 2014 .

Design and development of novel transdermal nanoemulgel for Alzheimer's disease: Pharmacokinetic, pharmacodynamic and biochemical investigations.

S. Talegaonkar, Tushar Madaan, S. Setya, 2019, Current drug delivery.

Appraisal of Transdermal Water-in-Oil Nanoemulgel of Selegiline HCl for the Effective Management of Parkinson’s Disease: Pharmacodynamic, Pharmacokinetic, and Biochemical Investigations

S. Talegaonkar, M. Tariq, Tushar Madaan, 2017, AAPS PharmSciTech.

Nanoemulsion in Drug Targeting

S. Talegaonkar, L. Negi, 2015 .

UPLC/Q-TOF-MS/MS METHOD FOR EVALUATION OF MOXIFLOXACIN LOADED NANOPLEXES AS VEHICLES FOR OCULAR DRUG DELIVERY

F. Ahmad, S. Talegaonkar, G. Jain, 2012 .

Berberine loaded dermal quality by design adapted chemically engineered lipid nano-constructs-gel formulation for the treatment of skin acne

M. Qureshi, S. Talegaonkar, M. H. Warsi, 2021, Journal of Drug Delivery Science and Technology.

Intranasal delivery: An approach to bypass the blood brain barrier

S. Talegaonkar, P. Mishra, 2004 .

Hybrid chitosan-based nanoparticulate systems for drug delivery

S. Talegaonkar, P. Kesharwani, R. Dandela, 2022, Hybrid Nanomaterials for Drug Delivery.

Preparation and Characterization of Oil in Water Nano-Reservoir Systems for Improved Oral Delivery of Atorvastatin

G. Mustafa, S. Talegaonkar, T. Bansal, 2009 .

Anterior uveal tract metastasis as the presenting feature of bronchial carcinoma.

S. Talegaonkar, 1969, The British journal of ophthalmology.

A STABILITY INDICATING HPTLC METHOD FOR THE ANALYSIS OF IRINOTECAN IN BULK DRUG AND MARKETED INJECTABLES

F. Ahmad, S. Talegaonkar, N. Akhtar, 2011 .

Structure, genome, infection cycle and clinical manifestations associated with Human Papillomavirus.

P. Mishra, Harshita Mishra, S. Talegaonkar, 2019, Current pharmaceutical biotechnology.

Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.

Vijay Kumar, Zeenat Iqbal, Sushama Talegaonkar, 2014, International journal of pharmaceutics.

An approach for lacidipine loaded gastroretentive formulation prepared by different methods for gastroparesis in diabetic patients.

F. Ahmad, S. Talegaonkar, Devender Singh, 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for Pylorospasm

Bhavna, F. Ahmad, S. Talegaonkar, 2009, Journal of microencapsulation.

Chondroitin sulfate-capped super-paramagnetic iron oxide nanoparticles as potential carriers of doxorubicin hydrochloride.

S. Mehdi, F. Ahmad, S. Talegaonkar, 2016, Carbohydrate polymers.

Assessing the potential of lignin nanoparticles as drug carrier: Synthesis, cytotoxicity and genotoxicity studies.

Seetha, P. Mishra, Harshita Mishra, 2020, International journal of biological macromolecules.

Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose.

F. Ahmad, S. Talegaonkar, P. Kesharwani, 2021, International journal of pharmaceutics.

Study of the Degradation Kinetics of Carvedilol by Use of a Validated Stability-Indicating LC Method

M. Rizwan, S. Talegaonkar, Asgar Ali, 2009 .

Melanoma treatment: from conventional to nanotechnology

P. Mishra, Harshita Mishra, S. Talegaonkar, 2018, Journal of Cancer Research and Clinical Oncology.

Emerging Role of CD44 Receptor as a Potential Target in Disease Diagnosis: A Patent Review.

F. Ahmad, S. Talegaonkar, Purnima Rawat, 2017, Recent patents on inflammation & allergy drug discovery.

Liquid Chromatographic Method for Irinotecan Estimation: Screening of P-gp Modulators

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2015, Indian journal of pharmaceutical sciences.

Developed and validated stability indicating HPLC method for the determination of epirubicin in bulk drug, marketed injection and polymeric nanoparticles

S. Talegaonkar, Anu T. Singh, Shindu C Thomas, 2018 .

Development of Novel lipid Nanoparticles for oral Bioavailability Enhancement of Irinotecan: In-vitro and In-vivo Investigations

S. Talegaonkar, M. Tariq, L. Negi, 2016 .

Aqueous Humor Pharmacokinetics of Dorzolamide Loaded PLGAChitosan Nanoparticles by Ultra Performance Liquid Chromatography

F. Ahmad, S. Talegaonkar, G. Jain, 2011 .

Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.

S. Talegaonkar, R. Khar, M. Jaggi, 2008, Talanta.

Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.

Zeenat Iqbal, Sushama Talegaonkar, S. Talegaonkar, 2015, Colloids and surfaces. B, Biointerfaces.

Addressing the potential toxicities of the non-specific P-glycoprotein modulation by amalgamation with targeted approach in MDR tumors.

S. Talegaonkar, M. Jaggi, L. Negi, 2014, Medical hypotheses.

Secondary iritis in homocystinuria.

S. Talegaonkar, 1968, Developmental Medicine & Child Neurology.

Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.

F. Ahmad, S. Talegaonkar, A. Panda, 2016, International journal of pharmaceutics.

Ceramic Nanoparticles: Fabrication Methods and Applications in Drug Delivery.

Harshita, P. Mishra, S. Talegaonkar, 2015, Current pharmaceutical design.

Investigation of ethosomes as surrogate carriers for bioactives

S. Talegaonkar, Devina Verma, Tahir Khuroo, 2016 .

Nanolipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer’s Disease

S. Talegaonkar, A. Bhattacharyya, N. Gautam, 2019, Nanobiotechnology in Neurodegenerative Diseases.

Metal nanoparticles: a theranostic nanotool against cancer.

P. Mishra, S. Talegaonkar, B. Vaidya, 2015, Drug discovery today.

Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.

S. Talegaonkar, M. Jaggi, L. Negi, 2014, International journal of pharmaceutics.

A logical approach to optimize the nanostructured lipid carrier system of irinotecan: efficient hybrid design methodology

S. Talegaonkar, M. Jaggi, L. Negi, 2013, Nanotechnology.

Recent advancement on albumin nanoparticles in treating lung carcinoma

S. Talegaonkar, P. Kesharwani, M. Amin, 2023, Journal of drug targeting.

Assessment of ocular pharmacokinetics and safety of Ganciclovir loaded nanoformulations.

F. Ahmad, S. Talegaonkar, S. Akhter, 2011, Journal of biomedical nanotechnology.

A validated stability-indicating LC method for estimation of etoposide in bulk and optimized self-nano emulsifying formulation: Kinetics and stability effects.

S. Talegaonkar, N. Akhtar, R. Khar, 2013, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

Emerging role of microemulsions in cosmetics.

M. Rizwan, F. Ahmad, S. Talegaonkar, 2008, Recent patents on drug delivery & formulation.

Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation

K. Manglani, D. Vohora, F. Ahmad, 2015, Pharmaceutical Research.

Development and validation of stability indicating reversed-phase liquid chromatographic method for simultaneous quantification of methotrexate and teriflunomide in nanoparticles and marketed formulation.

F. Ahmad, S. Talegaonkar, M. Aqil, 2018, Biomedical chromatography : BMC.

Components Screening and Influence of Surfactant and Cosurfactant on Nanoemulsion Formation

M. Rizwan, F. Ahmad, S. Talegaonkar, 2009 .

Enhancing safety and efficacy of bisphosphonates therapy by association with hydroxyapatite as adjuvant drug carrier

D. Vohora, F. Ahmad, S. Talegaonkar, 2014 .

Aripiprazole Loaded Polymeric Biodegradable Microspheres: Formulation and In Vitro Characterization

S. Talegaonkar, A. Mittal, M. Aqil, 2009 .

Recent advancements in lignin valorization and biomedical applications: A patent review.

P. Mishra, S. Talegaonkar, A. Ekielski, 2021, Recent patents on nanotechnology.

Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms

D. Vohora, S. Talegaonkar, M. Kumar, 2017, Osteoporosis and sarcopenia.

Polymeric nanoparticles as a platform for permeability enhancement of class III drug amikacin.

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2018, Colloids and surfaces. B, Biointerfaces.

Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.

S. Talegaonkar, A. Panda, Anu T. Singh, 2016, International journal of pharmaceutics.

Rhodamine-loaded, cross-linked, carboxymethyl cellulose sodium-coated super-paramagnetic iron oxide nanoparticles: Development and in vitro localization study for magnetic drug-targeting applications

F. Ahmad, S. Talegaonkar, N. Mallick, 2015 .

Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations

F. Ahmad, S. Talegaonkar, A. Verma, 2018, Pharmaceutical Research.

Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation

K. Manglani, Sarika Gupta, D. Vohora, 2015, Pharmaceutical Research.

Development of a high sensitivity RP-HPLC method and stress testing of imatinib mesylate 1

S. Talegaonkar, M. Jaggi, L. Negi, 2013 .

Wood-Based Cellulose Nanofibrils: Haemocompatibility and Impact on the Development and Behaviour of Drosophila melanogaster

S. Mukherjee, P. Mishra, Harshita Mishra, 2019, Biomolecules.

In vivo lung deposition and sub-acute inhalation toxicity studies of nano-sized alendronate sodium as an antidote for inhaled toxic substances in Sprague Dawley rats.

Rashid Ali, Gaurav Mittal, Farhan Jalees Ahmad, 2013, Environmental toxicology and pharmacology.

CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.

P. Mishra, S. Talegaonkar, P. Kesharwani, 2023, International journal of pharmaceutics.

A Regulatory Overview of Hip And Knee Joint Replacement Devices

S. Talegaonkar, H. Popli, Anmol Wadhwa, 2019, Applied Clinical Research, Clinical Trials and Regulatory Affairs.

Dental therapeutic systems.

F. Ahmad, S. Talegaonkar, G. Jain, 2008, Recent patents on drug delivery & formulation.

Stepping into Small Shoes: Gaining User Perspective on Appropriate Administration Devices for Paediatric Medication in India.

S. Talegaonkar, S. Salunke, Saba Abidi, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Uncovering Caregiver Concerns: 5 key issues that still remain unresolved in administration of oral medicines for children in India.

S. Talegaonkar, S. Salunke, Varsha Pradhan, 2023, European journal of pharmaceutics and biopharmaceutics.

Role of CD44 in tumour progression and strategies for targeting

F. Ahmad, S. Talegaonkar, Z. Iqbal, 2012, Journal of drug targeting.

Appraisal of Transdermal Water-in-Oil Nanoemulgel of Selegiline HCl for the Effective Management of Parkinson’s Disease: Pharmacodynamic, Pharmacokinetic, and Biochemical Investigations

S. Talegaonkar, M. Tariq, Tushar Madaan, 2017, AAPS PharmSciTech.

Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability

S. Talegaonkar, A. Bhattacharyya, 2019, AAPS PharmSciTech.

In vivo lung deposition and sub-acute inhalation toxicity studies of nano-sized alendronate sodium as an antidote for inhaled toxic substances in Sprague Dawley rats.

R. Ali, F. Ahmad, S. Talegaonkar, 2013, Environmental toxicology and pharmacology.

Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer.

S. Talegaonkar, M. Jaggi, L. Negi, 2015, International journal of biological macromolecules.

Metal nanoparticles: a theranostic nanotool against cancer.

P. Mishra, S. Talegaonkar, Harshita Sharma, 2015, Drug discovery today.

S. Talegaonkar, R. Khar, M. Jaggi, 2008, Talanta.

Synergistic anticancer activity of Sulphoraphane and Teriflunomide co loaded lignin nanoparticles against triple negative breast cancer: Targeted nanoparticle delivery and drug repurposing

S. Talegaonkar, L. Siddiqui, D. Dutta, 2024, Medical Hypotheses.